Poland· PL-100075006
Biodribin
A cladribine product containing cladribinum, registered in Poland by Sieć Badawcza Łukasiewicz – Instytut Chemii Przemysłowej im. Prof. I. Mościckiego. The same ATC class is registered in 14 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Cladribine is registered in 14 of 19 countries.
Countries holding a registration under ATC L01BB04 (cladribine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Cladribine · ATC L01BB04
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Cladribinum
- Manufacturer
- Sieć Badawcza Łukasiewicz – Instytut Chemii Przemysłowej im. Prof. I. Mościckiego
- Country
- Poland (PL)
- ATC code
- L01BB04
- ATC class
- Cladribine
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990713417
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
409 interactions on record for cladribine.
Graded by severity as the source publishes them — 326 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cladribine · interactions on record
409 records
- 326 severe
- 79 moderate
- 4 info
Most severe, free to view
- PrednisoloneA07EA01severe
- HydrocortisoneA07EA02severe
- PrednisoneA07EA03severe
- BetamethasoneA07EA04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cladribine in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCladribineHisun Pharmaceuticals USA, Inc.
- SpainLEUSTATIN 1 MG/ML SOLUCION PARA PERFUSIONAtnahs Pharma Netherlands Bv.
- CzechiaLEUJECTAtnahs Pharma Netherlands B.V., Amsterdam
- FinlandLeujectAtnahs Pharma Netherlands B.V.
- SwitzerlandLitak 10, Injektions- / InfusionslösungLipomed AG
- NetherlandsLeustatin 2 mg/ml oplossing voor injectieAtnahs Pharma Netherlands B.V.
- United KingdomLeustat 10mg/10ml solution for infusion vialsAtnahs Pharma UK Ltd
- CanadaCLADRIBINE INJECTIONGENERIC MEDICAL PARTNERS INC
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Leuject
- Belgium · Leustatin
- Bulgaria · Леуджект
- Czechia · Leuject
- Germany · Leustatin
- Spain · Leustatin
- Finland · Leuject
- France · Leustatine
- United Kingdom (Northern Ireland) · Cladribine Zentiva, Leustat
- Greece · Leustatin
- Croatia · Leuject
- Hungary · Leuject
- Iceland · Mavenclad
- Italy · Leustatin
- Liechtenstein · Mavenclad
- Luxembourg · Leustatin
- Netherlands · Leustatin
- Norway · Leuject, Mavenclad
- Portugal · Cladribina Generis, Leustatin
- Romania · Leuject
- Sweden · Leuject
- Slovenia · Leuject
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/edd7bad8-13d8-4264-a212-0d9ae02ded3d GET /v1/drugs/edd7bad8-13d8-4264-a212-0d9ae02ded3d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do infuzji",
"source": "urpl",
"strength": "1 mg/ml",
"packaging": "05909990713417 ¦ Lz ¦ 11300\n1 fiol. 10 ml",
"substance": "Cladribinum 10 mg/10 ml",
"common_name": "Cladribinum",
"pl_product_id": "100075006",
"pozwolenie_nr": "07134",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about cladribine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.